Ova donors demand compensation from government
By Asia News,
AsiaNews.it
| 02. 07. 2006
Seoul (AsiaNews) _ A coalition of 35 women_s groups filed a suit for compensation against the South Korean government on behalf of women suffering from side-effects after making uninformed ova donations to Prof Hwang Woo-suk for his research on stem cell embryos.
The women_s groups in association with Lawyers for a Democratic Society (Minbyun) claim that the donors who provided the _research material_ to the now disgraced researcher received no information on the side effects of excessive ova collection.
During the investigation into the fraudulent study, it was found that Hwang_s team used 2,221 ova, about fivefold the number Hwang had previously claimed, and that about 20 per cent of the donors have suffered side-effects from this invasive practice.
_Fifteen women donated eggs more than twice. The Mizmedi Hospital team even collected ova twice from a woman, who was hospitalized for side-effects after each donation,__ the women_s groups said in a statement. _It is an example of how the embryonic stem cell research, which received full national support, trampled on women_s human rights,_ the press release also said.
The groups...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...